致在公司集资方面有心得及有投资意向的朋友们...有企业计划书及其执行摘要备索。谢谢关注。
公司产品与在研项目：
"We provide modified nucleosides, nucleotides, and phosphoramidites (including triphosphates and phosphoramidites of therapeutic nucleos(t)ides, isotope-labeled nucleotides, fluorescent nucleotides, and nucleotide conjugates) for medical and biotechnological applications in genomics, nucleos(t)ide chemotherapy, oligonucleotide therapy, and diagnostics. With HIV/AIDS, liver disease, and cancer as primary areas of focus, we develop better or alternative chemical processes for nucleoside and nucleotide APIs (active pharmaceutical ingredient), manufacture APIs and related pharmaceutical intermediates, and develop product pipeline of new anti(retro)viral/anticancer agents based on screening of our molecule library of nucleosides and nucleotides by enzymatic assays of corresponding nucleotide triphosphates, and on concepts of nucleotide prodrugs and bifunctional dual drugs."
Look for funds for a startup biotech with therapeutic focus on infectious diseases and cancer. It develops novel nucleoside and nucleotide agents, etc.